The bacterium that causes Lyme disease is a master of disguise, changing its appearance to evade the immune system as it moves from the ticks that carry it to humans or animals.
Academic rigour, journalistic flair
Articles on Vaccines
Displaying 1 - 20 of 754 articles
Chlamydia is devastating for koalas, but the vaccine to prevent infection requires a booster shot. Recapturing the animals for their booster shot is costly and stresses them, but there’s a solution.
Only time and data will tell whether the CDC-recommended reformulated shots can stand their ground against the ever-changing SARS-CoV-2 variants.
Naomi Klein uses her frequent confusion with ‘doppelganger’ Naomi Wolf to spark an exploration of doubles, mirror-worlds, and the gulf between left and right.
The COVID pandemic made flu less severe. But now flu is back with a vengeance and all eyes are on Australia.
New research shows that breastfeeding rates peaked in 2020, a time of strict COVID restrictions.
Nearly 100,000 US children under age 5 are hospitalized each year for an RSV infection.
Specific beliefs may have more to do with people’s vaccine views than their religious affiliation – but it depends on which vaccine you’re talking about.
Flu vaccines remain the most effective method available to prevent flu illness, especially severe illness.
COVID truthers use four enticing promises to gain a loyal following.
New analysis answers questions about the ongoing effectiveness of COVID vaccines: How well they protect against infection, hospitalization and death months after initial doses or after a booster shot.
While mRNA vaccines are designed to last longer in the body than mRNA molecules typically would, they are also tested to ensure they are eliminated from livestock long before milking or slaughter.
Three factors that can speed up adoption of clinical research discoveries are context, tailoring resources and efficient knowledge sharing.
The newly approved RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
The first vaccine against respiratory syncytial virus is 83% effective.
Polio vaccines have been a massive public health victory in the US. But purely celebratory messaging overlooks the ongoing threat if vaccination rates fall.
Oropharyngeal cancer has now become more common than cervical cancer in the US and the UK.
Africa has come a long way, in the post-COVID era, in boosting the morale around local production investments among local and foreign companies. But more is needed.
Similar to the patterns seen with COVID-19, flu and RSV, HMPV is making a comeback after years of being repressed by people wearing masks and social distancing.
Countries must ensure adequate and full immunisation of every child to curb polio mutations.
Top contributors
-
Professorial Fellow, University of Canberra
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Associate Professor of Biology, Rochester Institute of Technology
-
Professor of Microbiology, School of Medicine, University of Washington
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Virologist, Queen's University Belfast
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Professor of Immunology, RMIT University
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Assistant Professor of Political Science, Oklahoma State University
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Senior Lecturer; MD, Victoria University
